Strategies for consistent and automated quantification of HDL proteome using data-independent acquisition

Strategies for consistent and automated quantification of HDL proteome using data-independent acquisition

The introduction of mass spectrometry-based proteomics has revolutionized the high-density lipoprotein (HDL) field, with the description, characterization, and implication of HDL-associated proteins in an array of pathologies. However, acquiring robust, reproducible data is still a challenge in the...

Full description

Bibliographic Details
Main Authors:	Douglas Ricardo Souza Junior, Amanda Ribeiro Martins Silva, Graziella Eliza Ronsein
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	Journal of Lipid Research
Subjects:	apolipoproteins data-independent acquisition high-density lipoprotein HDL lipoproteins proteomics
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227523000706

Similar Items

Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
by: Christine Bobin-Dubigeon, et al.
Published: (2022-02-01)

A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease
by: Alankrita Rani, et al.
Published: (2023-05-01)

HDL Isolated by Immunoaffinity, Ultracentrifugation, or Precipitation is Compositionally and Functionally Distinct
by: Michael Holzer, et al.
Published: (2022-12-01)

LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection
by: Alexina Orsoni, et al.
Published: (2011-12-01)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01)

The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism
by: Ewa Wieczorek, et al.
Published: (2021-12-01)

The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality
by: Kyung-Hyun Cho
Published: (2022-04-01)

Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity[S]
by: Tomáš Vaisar, et al.
Published: (2015-08-01)

Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
by: Alexandra Schlenck, et al.
Published: (1999-11-01)

HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study
by: Alexandra E. Butler, et al.
Published: (2023-03-01)

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome[S]
by: Fabiana Rached, et al.
Published: (2014-12-01)

Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL[S]
by: Naoko Sawada, et al.
Published: (2020-06-01)

A targeted proteomics method for quantifying plasma apolipoprotein kinetics in individual mice using stable isotope labeling
by: Baohai Shao, et al.
Published: (2024-04-01)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
by: Manuela Casula, et al.
Published: (2021-07-01)

Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
by: Oktawia Nilsson, et al.
Published: (2021-01-01)

HDL Composition, Heart Failure, and Its Comorbidities
by: Ahmed Diab, et al.
Published: (2022-03-01)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide <span style="font-variant: small-caps">d</span>-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
by: Andrea Rivas-Urbina, et al.
Published: (2020-05-01)

Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents
by: Skylar T. Chuang, et al.
Published: (2020-05-01)

Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population
by: Tara R. Price, et al.
Published: (2023-12-01)

Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles
by: Chuang ST, et al.
Published: (2017-11-01)

Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins
by: Shucun Qin, et al.
Published: (2000-02-01)

Efficacy and Safety of High-Density Lipoprotein/Apolipoprotein A1 Replacement Therapy in Humans and Mice With Atherosclerosis: A Systematic Review and Meta-Analysis
by: Ayiguli Abudukeremu, et al.
Published: (2021-08-01)

Abnormal HDL lipid and protein composition following pediatric cancer treatment: an associative study
by: Véronique Bélanger, et al.
Published: (2023-06-01)

Changes in HDL cholesterol, particles, and function associate with pediatric COVID-19 severity
by: Michele Mietus-Snyder, et al.
Published: (2022-10-01)

Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution
by: Susan J. Murdoch, et al.
Published: (2002-08-01)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
by: Monique F. M. Santana, et al.
Published: (2020-09-01)

Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function
by: Denys Bashtovyy, et al.
Published: (2011-03-01)

Proteomic and functional analysis of HDL subclasses in humans and rats: a proof-of-concept study
by: Canxia Huang, et al.
Published: (2023-06-01)

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
by: David Meriwether, et al.
Published: (2011-10-01)

High-Density Lipoproteins: A Role in Inflammation in COPD
by: Stanislav Kotlyarov
Published: (2022-07-01)

Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
by: Alma Nurtazina, et al.
Published: (2020-07-01)

The kringle IV type 2 domain variant 4925G>A causes the elusive association signal of the LPA pentanucleotide repeat
by: Rebecca Grüneis, et al.
Published: (2022-12-01)

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
by: Michael B. Boffa, et al.
Published: (2016-05-01)

Review of Laboratory Methods to Determine HDL and LDL Subclasses and Their Clinical Importance
by: Abdolreza Chary, et al.
Published: (2022-04-01)

Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway[S]
by: Nathalie Pamir, et al.
Published: (2016-02-01)

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
by: Saeed Shoar, et al.
Published: (2021-06-01)

Differential response to low-fat diet between low and normal HDL-cholesterol subjects
by: Bela Asztalos, et al.
Published: (2000-03-01)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Dustin Chernick, et al.
Published: (2020-09-01)

Structural basis of specific interactions of Lp-PLA2 with HDL revealed by hydrogen deuterium exchange mass spectrometry[S]
by: Jian Cao, et al.
Published: (2013-01-01)

Human apoA-I[Lys107del] mutation affects lipid surface behavior of apoA-I and its ability to form large nascent HDL
by: Irina N. Gorshkova, et al.
Published: (2023-02-01)